Illumina (ILMN) is a leading diagnostics & research business based in the US. It opened the day at $118.80 after a previous close of $117.61. During the day the price has varied from a low of $115.31 to a high of $119.19. The latest price was $115.60 (25 minute delay). Illumina is listed on the NASDAQ and employs 10,590 staff. All prices are listed in US Dollars.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Open | $118.80 |
|---|---|
| High | $119.19 |
| Low | $115.31 |
| Close | $115.60 |
| Previous close | $117.61 |
| Change | $-2.01 |
| Change % | -1.709% |
| Volume | 1,138,620 |
| 52-week range | $86.49 - $190.13 |
|---|---|
| 50-day moving average | $109.06 |
| 200-day moving average | $122.29 |
| Wall St. target price | $142.29 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-8.15 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $115.6 from 2024-07-23
| 1 week (2024-07-17) | -3.58% |
|---|---|
| 1 month (2024-06-24) | 4.86% |
| 3 months (2024-04-24) | -5.92% |
| 6 months (2024-01-24) | -18.02% |
| 1 year (2023-07-24) | -38.53% |
|---|---|
| 2 years (2022-07-21) | -44.15% |
| 3 years (2021-07-23) | 495.51 |
| 5 years (2019-07-24) | 304.01 |
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.296. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $345 million.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.5 billion |
|---|---|
| Gross profit TTM | $3.1 billion |
| Return on assets TTM | -0.5% |
| Return on equity TTM | -20.76% |
| Profit margin | -28.71% |
| Book value | $36.06 |
| Market Capitalization | $18.4 billion |
TTM: trailing 12 months
We're not expecting Illumina to pay a dividend over the next 12 months.
Illumina's shares were split on a 1028:1000 basis on 24 June 2024. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1028 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 2.7% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Over the last 12 months, Illumina's shares have ranged in value from as little as $86.4933 up to $190.1296. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 1.15. This would suggest that Illumina's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.